Cargando…
Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges
Autores principales: | Deslée, G., Zysman, M., Burgel, P.-R., Perez, T., Boyer, L., Gonzalez, J., Roche, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SPLF and Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212957/ https://www.ncbi.nlm.nih.gov/pubmed/32498023 http://dx.doi.org/10.1016/j.resmer.2020.100764 |
Ejemplares similares
-
The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease
por: Regard, Lucile, et al.
Publicado: (2023) -
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease
por: Perez, Thierry, et al.
Publicado: (2015) -
Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease
por: Burgel, Pierre-Régis, et al.
Publicado: (2017) -
Mucus Plugs in Medium-sized Airways: A Novel Imaging Biomarker for Phenotyping Chronic Obstructive Pulmonary Disease
por: Chassagnon, Guillaume, et al.
Publicado: (2021) -
Prevalence and management of chronic breathlessness in COPD in a tertiary care center
por: Carette, H., et al.
Publicado: (2019)